These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7740500)
1. The APTT monitoring of heparin--the ISTH/ICSH collaborative study. Van der Velde EA; Poller L Thromb Haemost; 1995 Jan; 73(1):73-81. PubMed ID: 7740500 [TBL] [Abstract][Full Text] [Related]
2. Standardization of coagulation tests. Opartkiattikul N Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265 [TBL] [Abstract][Full Text] [Related]
3. Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin. Toulon P; Boutière B; Horellou MH; Trzeciak MC; Samama MM Thromb Haemost; 1998 Jul; 80(1):104-8. PubMed ID: 9684794 [TBL] [Abstract][Full Text] [Related]
4. A simplified procedure for thromboplastin calibration--the usefulness of lyophilized plasmas assessed in a collaborative study. Tripodi A; Chantarangkul V; Manotti C; Poggi M; Braga M; Akkawat B; Bucciarelli P; Mannucci PM Thromb Haemost; 1996 Feb; 75(2):309-12. PubMed ID: 8815582 [TBL] [Abstract][Full Text] [Related]
5. Field study of lyophilized calibrant plasmas for fresh plasma INR determination. van den Besselaar AM; Houbouyan-Réveillard LL Thromb Haemost; 2002 Feb; 87(2):277-81. PubMed ID: 11859852 [TBL] [Abstract][Full Text] [Related]
6. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time]. Kagawa K; Fukutake K Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964 [TBL] [Abstract][Full Text] [Related]
7. Calibration of BCT/441, the ICSH reference preparation for thromboplastin. Thomson JM; Darby KV; Poller L Thromb Haemost; 1986 Jun; 55(3):379-82. PubMed ID: 3750267 [TBL] [Abstract][Full Text] [Related]
8. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays. Kitchen S; Preston FE Thromb Haemost; 1996 May; 75(5):734-9. PubMed ID: 8725715 [TBL] [Abstract][Full Text] [Related]
9. Monitoring heparin therapy: relationships between the activated partial thromboplastin time and heparin assays based on ex-vivo heparin samples. van den Besselaar AM; Meeuwisse-Braun J; Bertina RM Thromb Haemost; 1990 Feb; 63(1):16-23. PubMed ID: 2339357 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin. Ip BK; Thomson AR; Moriarty HT Pathology; 2001 Aug; 33(3):347-52. PubMed ID: 11523938 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of cumulative summation of differences method for determining APTT reagent suitability. Findlater SH Clin Lab Sci; 2012; 25(3):142-8. PubMed ID: 22953513 [TBL] [Abstract][Full Text] [Related]
12. Results of calibration by the Dutch National Reference Laboratory of the thromboplastins included in the ICTH/ICSH collaborative study of prothrombin time standardization. Loeliger EA; van Halem-Visser LP Thromb Haemost; 1979 Dec; 42(4):1128-31. PubMed ID: 542925 [TBL] [Abstract][Full Text] [Related]
13. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization]. Mischke R Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference. Okuda M; Yamamoto Y Clin Lab Haematol; 2004 Jun; 26(3):215-23. PubMed ID: 15163321 [TBL] [Abstract][Full Text] [Related]
15. Establishing a new target range for unfractionated heparin for acute coronary syndromes. Lee MS; Menon V; Schappert J; Wilentz JR; Singh V; Hochman JS J Thromb Thrombolysis; 2004 Apr; 17(2):121-6. PubMed ID: 15306747 [TBL] [Abstract][Full Text] [Related]
16. Preparation of lyophilized partial thromboplastin time reagent composed of synthetic phospholipids: usefulness for monitoring heparin therapy. van den Besselaar AM; Neuteboom J; Meeuwisse-Braun J; Bertina RM Clin Chem; 1997 Jul; 43(7):1215-22. PubMed ID: 9216459 [TBL] [Abstract][Full Text] [Related]
17. Multicenter evaluation of lyophilized and deep-frozen plasmas for assignment of the International Normalized Ratio. van den Besselaar AM; Houbouyan-Reveillard LL; Aillaud MF; Denson KW; Droullé C; Johnston M; Kitchen S; Lindahl TL; Marren M; Martinuzzo ME; Tripodi A; Vergnes C Thromb Haemost; 1999 Nov; 82(5):1451-5. PubMed ID: 10595637 [TBL] [Abstract][Full Text] [Related]
18. Calibration of local systems with lyophilized calibrant plasmas improves the interlaboratory variability of the INR in the Italian external quality assessment scheme. Chantarangkul V; Tripodi A; Cesana BM; Mannucci PM Thromb Haemost; 1999 Dec; 82(6):1621-6. PubMed ID: 10613645 [TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]